GLSI
Greenwich LifeSciences, Inc.
Key Financials
Net Income
$-15788809
↓ 77.6%
Operating Income
$-16011817
↓ 71.7%
Total Liabilities
$1.6M
↑ 429.8%
Total Assets
$4.1M
↓ 41.5%
Cash & Equivalents
$4.1M
↓ 41.5%
EPS (Diluted)
$-1.21
↓ 75.4%
Operating Cash Flow
$-7266543.00
↓ 12.2%
Shareholders' Equity
$2.5M
↓ 62.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GLSI |
| Company Name | Greenwich LifeSciences, Inc. |
| CIK | 1799788 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 203-434-3290 |